TLSI · TriSalus Life Sciences, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Our continuation as a going concern is dependent on our ability to generate sufficient cash flows from operations and/or obtain additional capital through equity or debt financings, partnerships, collaborations, strategic alliances and/or licensing arrangements to carry out our long-term business strategy.”View the 10-Q filed May 12, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score Cluster buy
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-01 | Patience David |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted. |
Common Stock
|
14,650 |
| 2026-06-30 | Marshak Richard |
Chief Commercial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
Common Stock
|
561 |
| 2026-06-30 | Szela Mary T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
Common Stock
|
3,990 |
| 2026-06-29 | Marshall Richard Henry |
Chief Medical Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. |
Employee Stock Option (right to buy)
|
120,000 |
| 2026-06-29 | Marshall Richard Henry |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
Common Stock
|
60,000 |
| 2026-05-15 | Patience David |
Chief Financial Officer |
Buy↑
|
Common Stock
|
7,100 |
| 2026-05-15 | Szela Mary T |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 39,682 shares at a weighted average price of $2.59, with the Reporting Person's sales of 4,358 shares of common stock at a price per share of $4.13 on March 11, 2026 and of 15,944 shares of common stock at a price per share of $3.85. The prior sales represented shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person, and did not represent discretionary sales by the Reporting Person. The Reporting Person paid $27,573.70 to the Issuer, representing the full amount of profit realized in connection with the short-swing transaction. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
Common Stock
|
39,682 |
| 2026-05-15 | Stansky Michael P |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member. |
Common Stock
(I)
|
200,000 |
| 2026-05-15 | Wahlstrom Mats |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
Common Stock
|
60,000 |
| 2026-05-15 | Stansky Michael P |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
Common Stock
|
410,000 |
| 2026-05-15 | Gordon Gary B. |
Director |
Buy↑
|
Common Stock
|
10,000 |
| 2026-05-15 | Marshak Richard |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person. |
Common Stock
|
543 |
| 2026-05-14 | Wahlstrom Mats |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
34,226 |
| 2026-05-14 | Valle William |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Director Stock Option (right to buy)
|
56,403 |
| 2026-05-14 | Wahlstrom Mats |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Director Stock Option (right to buy)
|
75,204 |
| 2026-05-14 | HICKS KERRY R |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Director Stock Option (right to buy)
|
56,403 |
| 2026-05-14 | Gordon Gary B. |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Director Stock Option (right to buy)
|
56,403 |
| 2026-05-14 | Stansky Michael P |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
20,089 |
| 2026-05-14 | Stansky Michael P |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
23,501 |
| 2026-05-14 | Wahlstrom Mats |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
37,602 |
| 2026-05-14 | Stansky Michael P |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Director Stock Option (right to buy)
|
47,003 |
| 2026-05-14 | MATLIN DAVID J |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Director Stock Option (right to buy)
|
56,403 |
| 2026-05-14 | HICKS KERRY R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
28,201 |
| 2026-05-14 | MATLIN DAVID J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
23,065 |
| 2026-05-14 | Gordon Gary B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
24,553 |
| 2026-05-14 | Valle William |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
28,201 |
| 2026-05-14 | Gordon Gary B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
28,201 |
| 2026-05-14 | Valle William |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
24,553 |
| 2026-05-14 | MATLIN DAVID J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
Common Stock
|
28,201 |
| 2026-03-17 | Szela Mary T |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
15,944 |
| 2026-03-16 | Devlin Jodi |
Chief of Clinical Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
273 |
| 2026-03-16 | Marshak Richard |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
419 |
| 2026-03-16 | Cox Bryan F. |
Chief of Research |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
579 |
| 2026-03-16 | Stevens Jennifer |
Chief Regulatory Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
774 |
| 2026-03-12 | Cox Bryan F. |
Chief of Research |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,467 |
| 2026-03-12 | Devlin Jodi |
Chief of Clinical Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,772 |
| 2026-03-12 | Marshak Richard |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,589 |
| 2026-03-12 | Stevens Jennifer |
Chief Regulatory Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,552 |
| 2026-03-11 | Devlin Jodi |
Chief of Clinical Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,162 |
| 2026-03-11 | Stevens Jennifer |
Chief Regulatory Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,204 |
| 2026-03-11 | Cox Bryan F. |
Chief of Research |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,138 |
| 2026-03-11 | Szela Mary T |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
4,358 |
| 2026-03-11 | Marshak Richard |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. |
Common Stock
|
1,449 |
| 2026-02-23 | Szela Mary T |
Director |
Buy↑
|
Common Stock
|
30,487 |
| 2026-02-23 | Valle William |
Director |
Buy↑
|
Common Stock
|
30,487 |
| 2026-02-23 | Stansky Michael P |
Director |
Buy↑
|
Common Stock
|
243,900 |
| 2026-02-23 | Patience David |
Chief Financial Officer |
Buy↑
|
Common Stock
|
3,657 |
| 2026-02-23 | Stansky Michael P |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
These securities were purchased by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member. |
Common Stock
(I)
|
117,198 |
| 2026-02-23 | Gordon Gary B. |
Director |
Buy↑
|
Common Stock
|
9,756 |
| 2026-02-04 | Stansky Michael P |
Director |
Award↑
Filing footnotes — Director Stock Option (right to buy) (Direct)
The shares subject to this stock option vest in three equal annual installments commencing on February 4, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
Director Stock Option (right to buy)
|
92,537 |